Registro:

Referencias:

• Ogura, K., Koyama, T., Enzymatic aspects of isoprenoid chain elongation (1998) Chem Rev., 98, pp. 1263-1276
• Kellogg, B.A., Poulter, C.D., Chain elongation in the isoprenoid biosynthetic pathway (1997) Curr Opin Chem Biol., 1, pp. 570-578
• Eberl, M., Hintz, M., Reichenberg, A., Microbial isoprenoid biosynthesis and human ? T cell activation (2003) FEBS Lett., 544, pp. 4-10
• Zhao, L., Chang, W.-C., Xiao, Y., Methylerythritol phosphate pathway of isoprenoid biosynthesis (2013) Annu Rev Biochem., 82, pp. 497-530
• Reszka, A.A., Rodan, G.A., Nitrogen-containing bisphosphonate mechanism of action (2004) Mini Rev Med Chem., 4, pp. 711-719
• Miller, K., Erez, R., Segal, E., Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate (2009) Angew Chem Int Ed., 48, pp. 2949-2954
• Clézardin, P., Massaia, M., Nitrogen-containing bisphosphonates and cancer immunotherapy (2010) Curr Pharm Des., 16, pp. 3007-3014
• Coleman, R.E., Risks and benefits of bisphosphonates (2008) British J Cancer., 98, pp. 1736-1740
• Zhang, Y., Cao, R., Yin, F., Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: An X-ray and NMR investigation (2009) J Am Chem Soc., 131, pp. 5153-5162
• Reddy, R., Dietrich, E., Lafontaine, Y., Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitis (2008) Chem Med Chem., 3, pp. 1863-1868
• Sanders, J.M., Ghosh, S., Chan, J.M.W., Quantitative structure-activity relationships for ? T cell activation by bisphosphonates (2004) J Med Chem., 47, pp. 375-384
• Rodriguez, J.B., Szajnman, S.H., New antibacterials for the treatment of toxoplasmosis; A patent review (2012) Expert Opinion Ther Patents., 22, pp. 311-333
• Urbina, J.A., Moreno, B., Vierkotter, S., Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs (1999) J Biol Chem., 274, pp. 33609-33615
• Ghosh, S., Chan, J.M.W., Lea, C.R., Effects of bisphosphonates on the growth of Entamoeba histolytica and plasmodium species in vitro and in vivo (2004) J Med Chem., 47, pp. 175-187
• Martin, M.B., Grimley, J.S., Lewis, J.C., Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy (2001) J Med Chem., 44, pp. 909-916
• Martin, M.B., Sanders, J.M., Kendrick, H., Activity of bisphosphonates against Trypanosoma brucei rhodesiense (2002) J Med Chem., 45, pp. 2904-2914
• Yardley, V., Khan, A.A., Martin, M.B., In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii (2002) Antimicrob Agents Chemother., 46, pp. 929-931
• Blanchard, L., Karst, F., Characterization of a lysine-to-glutamic acid mutation in a conservative sequence of farnesyl diphosphate synthase from Saccharomyces cerevisiae (1993) Gene., 125, pp. 185-189
• Song, L., Poulter, C.D., Yeast farnesyl-diphosphate synthase: Site-directed mutagenesis of residues in highly conserved prenyltransferase domains i and II (1994) Proc Natl Acad Sci USA., 91, pp. 3044-3048
• Sun, S., McKenna, C.E., Farnesyl pyrophosphate synthase modulators: A patent review(2006-2010) (2011) Expert Opinion Ther Patents., 21, pp. 1433-1451
• Clarke, S., Protein isoprenylation and methylation at carboxyl-terminal cysteine residues (1992) Annu Rev Biochem., 61, pp. 355-386
• Luckman, S.P., Hughes, D.E., Coxon, F.P., Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras (1998) J Bone Miner Res., 13, pp. 581-589
• Zhang, F.L., Casey, P.J., Protein prenylation: Molecular mechanisms and functional consequences (1996) Annu Rev Biochem., 65, pp. 241-269
• Kitten, G.T., Nigg, E.A., The CAAX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2 (1991) J Cell Biol., 113, pp. 13-23
• Hancock, J.F., Magee, A.I., Childs, J.E., All Ras proteins are polyisoprenylated but only some are palmitoylated (1989) Cell., 57, pp. 1167-1177
• Eastman, R.T., White, J., Hucke, O., Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum (2005) J Biol Chem., 280, pp. 13554-13559
• Yokoyama, K., Trobridge, P., Buckner, F.S., The effects of protein farnesyltransferase inhibitors on trypanosomatids: Inhibition of protein farnesylation and cell growth (1998) Mol Biochem Parasitol., 94, pp. 87-97
• Yokoyama, K., Trobridge, P., Buckner, F.S., Protein Farnesyltransferase from Trypanosoma brucei: A HETERODIMER of 61-AND 65-kDa SUBUNITS AS A NEW TARGET for ANTIPARASITE THERAPEUTICS (1998) J Biol Chem., 273, pp. 26497-26505
• Cuevas, I.C., Rohloff, P., Sanchez, D.O., Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi (2005) Eukaryot Cell., 4, pp. 1550-1561
• Lynen, F., Agranoff, B.W., Eggerer, H., ?,?-Dimethyl-allyl-pyrophosphat und Geranyl-pyrophosphat, biologische Vorstufen des Squalens Zur Biosynthese der Terpene, VI1) (1959) Angew Chem., 71, pp. 657-663
• Roelofs, A.J., Thompson, K., Ebetino, F.H., Bisphosphonates: Molecular mechanisms of action and effects on bone cells, monocytes and macrophages (2010) Curr Pharm Des., 16, pp. 2950-2960
• Fleisch, H., Russell, R.G.G., Straumann, F., Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis (1966) Nature., 212, pp. 901-903
• Francis, M.D., Graham, R.G.G., Russell, G., Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo (1969) Science., 165, pp. 1264-1266
• Fleisch, H., Graham, R.G.G., Russell, G., Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo (1969) Science., 165, pp. 1262-1264
• Russell, R.G.G., Bisphosphonates: The first 40 years (2011) Bone., 49, pp. 2-19
• Reszka, A.A., Rodan, G.A., Mechanism of action of bisphosphonates (2003) Curr Osteoporos Rep., 1, pp. 45-52
• Russell, R.G.G., Rogers, J.M., Bisphosphonates: From the laboratory to the clinic and back again (1999) Bone., 25, pp. 97-106
• Drake, M.T., Clarke, B.L., Khosla, S., Bisphosphonates: Mechanism of action and role in clinical practice (2008) Mayo Clin Proc., 83, pp. 1032-1045
• Plotkin, L.I., Weinstein, R.S., Parfitt, A.M., Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin (1999) J Clin Invest., 104, pp. 1363-1374
• Plotkin, L.I., Aguirre, J.I., Kousteni, S., Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation (2005) J Biol Chem., 280, pp. 7317-7325
• Gumienna-Kontecka, E., Silvagni, R., Lipinski, R., Bisphosphonate chelating agents: Complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues (2002) Inorg Chimica Acta., 339, pp. 111-118
• Crisponi, G., Nurchi, V.M., Pivetta, T., Towards a new attenuating compound: A potentiometric, spectrophotometric and NMR equilibrium study on Fe(III), Al(III) and a new tetradentate mixed bisphosphonate-hydroxypyridinonate ligand (2008) J Inorg Biochem., 102, pp. 1486-1494
• Gumienna-Kontecka, E., Jezierska, J., Lecouvey, M., Bisphosphonate chelating agents. Coordination ability of 1-phenyl-1-hydroxymethylene bisphosphonate towards Cu2+ ions (2002) J Inorg Biochem., 89, pp. 13-17
• Dolbecq, A., Mialane, P., Sécheresse, F., Functionalized polyoxometalates with covalently linked bisphosphonate, N-donor or carboxylate ligands: From electrocatalytic to optical properties (2012) Chem Commun., 48, pp. 8299-8316
• Ebetino, F.H., Francis, M.D., Rogers, M.J., Mechanisms of action of etidronate and other bisphosphonates (1998) Rev Contemp Pharmacother., 9, pp. 233-243
• Matczak-Jon, E., Kurzak, B., Kamecka, A., Interactions of zinc(II), magnesium(II) and calcium(II) with aminomethane-1,1-diphosphonic acids in aqueous solutions (2002) Polyhedron., 21, pp. 321-332
• Van Beek, E., Löwik, C., Que, I., Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group (1996) J Bone Miner Res., 11, pp. 1492-1497
• Marma, M.S., Xia, Z., Stewart, C., Synthesis and biological evaluation of ?-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate (2007) J Med Chem., 50, pp. 5967-5975
• McKenna, C.E., Shen, P.-D., Fluorination of methanediphosphonate esters by perchloryl fluoride. Synthesis of fluoromethanediphosphonic acid and difluoromethanediphosphonic acid (1981) J Org Chem., 46, pp. 4573-4576
• Romanenko, V.D., Kukhar, V.P., Fluorinated phosphonates: Synthesis and biomedical application (2006) Chem Rev., 106, pp. 3868-3935
• Berkowitz, D.B., Bose, M., (?-Monofluoroalkyl)phosphonates: A class of isoacidic and "tunable" mimics of biological phosphates (2001) J Fluorine Chem., 112, pp. 13-33
• Blackburn, G.M., England, D.A., Kolkmann, F., Monofluoro-and difluoromethylenebisphosphonic acids: Isopolar analogues of pyrophosphoric acid (1981) Chem Commun., 1981, pp. 930-932
• Dhar, M.K., Koul, A., Kaul, S., Farnesyl pyrophosphate synthase: A key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development (2013) New Biotechnology., 30, pp. 115-123
• Ebetino, F.H., Hogan, A.-M.L., Sun, S., The relationship between the chemistry and biological activity of the bisphosphonates (2011) Bone., 49, pp. 20-33
• Ohno, K., Mori, K., Orita, M., Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase (2011) Curr Med Chem., 18, pp. 220-233
• Cornforth, J.W., Cornforth, R.H., Popják, G., Studies on the biosynthesis of cholesterol. XX. Steric course of decarboxylation of 5-pyrophosphomevalonate and of the carbon to carbon bond formation in the biosynthesis of farnesyl pyrophosphate (1966) J Biol Chem., 241, pp. 3970-3987
• Kloer, D.P., Welsch, R., Beyer, P., Structure and reaction geometry of geranylgeranyl diphosphate synthase from Sinapis alba (2006) Biochemistry., 45, pp. 15197-15204
• Gabelli, S.B., McLellan, J.S., Montalvetti, A., Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design (2006) Proteins., 62, pp. 80-88
• Martin, M.B., Arnold, W., Heath, H.T., Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis (1999) Biochem Biophys Res Commun., 263, pp. 754-758
• Kavanagh, K.L., Guo, K., Dunford, J.E., The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs (2006) Proc Natl Acad Sci USA., 103, pp. 7829-7834
• Rondeau, J.-M., Bitsch, F., Bourgier, E., Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs (2006) ChemMedChem., 1, pp. 267-273
• De Schutter, J.W., Park, J., Leung, C.Y., Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: Implications to drug discovery for neurodegenerative diseases (2014) J Med Chem., 57, pp. 5764-5776
• Park, J., Lin, Y.-S., De Schutter, J.W., Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure (2012) BMC Struct Biol., 12, p. 32
• Park, J., Lin, Y.-S., Tsantrizos, Y.S., Structure of human farnesyl pyrophosphate synthase in complex with an aminopyridine bisphosphonate and two molecules of inorganic phosphate (2014) Acta Crystallogr Sect F Struct Biol Commun., 70, pp. 299-304
• Leung, C.Y., Park, J., De Schutter, J.W., Thienopyrimidine bisphosphonate(ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: Optimization and characterization of the mode of inhibition (2013) J Med Chem., 56, pp. 7939-7950
• Lin, Y.-S., Park, J., De Schutter, J.W., Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: Apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells (2012) J Med Chem., 55, pp. 3201-3215
• Tarshis, L.C., Yan, M., Poulter, C.D., Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-Å resolution (1994) Biochemistry., 33, pp. 10871-10877
• Tarshis, L.C., Proteau, P.J., Kellogg, B.A., Regulation of product chain length by isoprenyl diphosphate synthases (1996) Proc Natl Acad Sci USA., 93, pp. 15018-15023
• Guo, R.-T., Cao, R., Liang, P.-H., Bisphosphonates target multiple sites in both cis-and trans-prenyltransferases (2007) Proc Natl Acad Sci USA., 104, pp. 10022-10027
• Huang, C.-H., Gabelli, S.B., Oldfield, E., Binding of nitrogen-containing bisphosphonates(N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer (2010) Proteins., 78, pp. 888-899
• Aripirala, S., Szajnman, S.H., Jakoncic, J., Design, synthesis, calorimetry, and crystallographic analysis of 2-alkylaminoethyl-1,1-bisphosphonates as inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase (2012) J Med Chem., 55, pp. 6445-6454
• Cao, R., Chen, C.K.M., Guo, R.-T., Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases (2008) Proteins., 73, pp. 431-439
• Mao, J., Gao, Y.-G., Odeh, S., Crystallization and preliminary X-ray diffraction study of the farnesyl diphosphate synthase from Trypanosoma brucei (2004) Acta Crystallogr D Biol Crystallogr., 60, pp. 1863-1866
• Aripirala, S., Gonzalez-Pacanowska, D., Oldfield, E., Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates (2014) Acta Crystallogr Sect D Biol Crystallogr., 70, pp. 802-810
• Artz, J.D., Wernimont, A.K., Dunford, J.E., Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from plasmodium parasites (2011) J Biol Chem., 286, pp. 3315-3322
• Wang, W., Dong, C., McNeil, M., The structural basis of chain length control in Rv1086 (2008) J Mol Biol., 381, pp. 129-140
• Hosfield, D.J., Zhang, Y., Dougan, D.R., Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis (2003) J Biol Chem., 278, pp. 18401-18407
• Roberts, E., Eargle, J., Wright, D., MultiSeq: Unifying sequence and structure data for evolutionary analysis (2006) BMC Bioinformatics., 7, p. 382
• Humphrey, W., Dalke, A., Schulten, K., VMD: Visual molecular dynamics (1996) J Molec Graphics., 14, pp. 33-38
• King, H.L., Jr., Rilling, H.C., Avian liver prenyltransferase. The role of metal in substrate binding and the orientation of substrates during catalysis (1977) Biochemistry., 16, pp. 3815-3819
• Liu, Y.-L., Cao, R., Wang, Y., Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries (2015) ACS Med Chem Lett., 6, pp. 349-354
• Ling, Y., Li, Z.-H., Miranda, K., The farnesyldiphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates (2007) J Biol Chem., 282, pp. 30804-30816
• Biasini, M., Bienert, S., Waterhouse, A., SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information (2014) Nucleic Acids Res., 42, pp. W252-W258
• Arnold, K., Bordoli, L., Kopp, J., The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling (2006) Bioinformatics., 22, pp. 195-201
• Kiefer, F., Arnold, K., Künzli, M., The SWISS-MODEL Repository and associated resources (2009) Nucleic Acids Res., 37, pp. D387-D392
• Chan, H.-C., Feng, X., Ko, T.-P., Structure and inhibition of tuberculosinol synthase and decaprenyl diphosphate synthase from Mycobacterium tuberculosis (2014) J Am Chem Soc., 136, pp. 2892-2896
• Rosso, V.S., Szajnman, S.H., Malayil, L., Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase (2011) Bioorg Med Chem., 19, pp. 2211-2217
• Szajnman, S.H., Garcá Liñares, G.E., Li, Z.-H., Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase (2008) Bioorg Med Chem., 16, pp. 3283-3290
• Ohnuma, S., Conversion from farnesyl diphosphate synthase to geranylgeranyl diphosphate synthase by random chemical mutagenesis (1996) J Biol Chem., 271, pp. 10087-10095
• Yokoyama, T., Mizuguchi, M., Ostermann, A., Protonation state and hydration of bisphosphonate bound to farnesyl pyrophosphate synthase (2015) J Med Chem., 58, pp. 7549-7556
• Ferrer-Casal, M., Li, C., Galizzi, M., New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase (2014) Bioorg Med Chem., 22, pp. 398-405
• Demoro, B., Caruso, F., Rossi, M., Risedronate metal complexes potentially active against Chagas disease (2010) J Inorg Biochem., 104, pp. 1252-1258
• Szajnman, S.H., Montalvetti, A., Wang, Y., Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase (2003) Bioorg Med Chem Lett., 13, pp. 3231-3235
• Szajnman, S.H., Rosso, V.S., Malayil, L., Design, synthesis and biological evaluation of 1-(fluoroalkylidene)-1,1-bisphosphonic acids against Toxoplasma gondii targeting farnesyl diphosphate synthase (2012) Org Biomol Chem., 10, pp. 1424-1433
• Recher, M., Barboza, A.P., Li, Z.-H., Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents (2013) Eur J Med Chem., 60, pp. 431-440
• Silverman, R.B., (1999) The Organic Chemistry of Drug Design and Drug Action, pp. 171-172. , San Diego: Academic Press
• Rich, D.H., Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analog inhibitor (1985) J Med Chem., 28, pp. 263-273
• Bergstrom, J.D., Bostedor, R.G., Masarachia, P.J., Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase (2000) Arch Biochem Biophys., 373, pp. 231-241
• Dunford, J.E., Kwaasi, A.A., Rogers, M.J., Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: Time-dependent inhibition of human farnesyl pyrophosphate synthase (2008) J Med Chem., 51, pp. 2187-2195
• Ebetino, F.H., Dunford, J.E., Lundy, M.W., A mirror image pair of bisphosphonate analogs further demonstrates the mode of binding of the bisphosphonates in farnexyl pyrophosphate synthase (2008) Bone., 42, pp. S36-S37
• Tsoumpra, M.K., Muniz, J.R., Barnett, B.L., The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants (2015) Bone., 81, pp. 478-486
• Cotesta, S., Jahnke, W., Rondeau, J.M., (2010) Phenylalkyl-imidazolebisphosphonate Compounds
• Gao, J., Liu, J., Qiu, Y., Multi-target-directed design, syntheses, and characterization of fluorescent bisphosphonate derivatives as multifunctional enzyme inhibitors in mevalonate pathway (2013) Biochim Biophys Acta., 1830, pp. 3635-3642
• Gao, J., Chu, X., Qiu, Y., Discovery of potent inhibitor for farnesyl pyrophosphate synthase in the mevalonate pathway (2010) Chem Commun., 46, pp. 5340-5342
• Kieczykowski, G.R., Jobson, R.B., Melillo, D.G., Preparation of(4-amino-1-hydroxybutylidene) bisphosphonic acid sodium salt, MK-217(alendronate sodium). An improved procedure for the preparation of 1-hydroxy-1,1-bisphosphonic acids (1995) J Org Chem., 60, pp. 8310-8312
• Bhattacharya, A.K., Thyagarajan, G., The Michaelis-Arbuzov rearrangement (1981) Chem Rev., 81, pp. 415-430
• Pudovik, A.N., Konovalova, I.V., Addition reactions of esters of phosphorus( III) acids with unsaturated systems (1979) Synthesis., 1979, pp. 81-96
• Lazzarato, L., Rolando, B., Lolli, M.L., Synthesis of NO-donor bisphosphonates and their in-vitro action on bone resorption (2005) J Med Chem., 48, pp. 1322-1329
• Vachal, P., Hale, J.J., Lu, Z., Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis (2006) J Med Chem., 49, pp. 3060-3063
• Kolodyazhnaya, A.O., Kolodyazhnaya, O.O., Kolodyazhnyi, O.I., An efficient method for the phosphonation of C=X compounds (2010) Russian J General Chem., 80, pp. 709-722
• Rodriguez, J.B., Tetraethyl Vinylidenebisphosphonate: A versatile synthon for the preparation of bisphosphonates (2014) Synthesis., 46, pp. 1129-1142
• Degenhardt, C.R., Burdsall, D.C., Synthesis of ethenylidenebis(phosphonic acid) and its tetraalkyl esters (1986) J Org Chem., 51, pp. 3488-3490
• Lolli, M.L., Lazzarato, L., Di Stilo, A., Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate (2002) J Organomet Chem., 650, pp. 77-83
• Wasielewski, C., Antczak, K., Aminophosphonic acids; XVI1. A new and facile synthesis of phosphinothricine and 2-amino-4-phosphonobutanoic acid (1981) Synthesis., 1981, pp. 540-541
• Kurzak, B., Goldeman, W., Szpak, M., Synthesis of N-methyl alkylaminomethane-1,1-diphosphonic acids and evaluation of their complex-formation abilities towards copper(II) (2015) Polyhedron., 85, pp. 675-684
• Liu, J., Liu, W., Ge, H., Syntheses and characterization of nonbisphosphonate quinoline derivatives as new FPPS inhibitors (2014) Biochim Biophys Acta., 1840, pp. 1051-1062
• Lindert, S., Zhu, W., Liu, Y.-L., Farnesyl diphosphate synthase inhibitors from in silico screening (2013) Chem Biol Drug Des., 81, pp. 742-748
• Jahnke, W., Rondeau, J.-M., Cotesta, S., Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery (2010) Nat Chem Biol., 6, pp. 660-666
• Marzinzik, A.L., Amstutz, R., Bold, G., Discovery of novel allosteric non-bisphosphonate inhibitors of farnesyl pyrophosphate synthase by integrated lead finding (2015) ChemMedChem., 10, pp. 1884-1891
• Jahnke, W., Bold, G., Marzinzik, A.L., A general strategy for targeting drugs to bone (2015) Angew Chem Int Ed., 54, pp. 14575-14579

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------